Clinic Hours

Monday to Friday
8:30 am to 5:00 pm

Pharmacy Hours

Monday to Friday
8:30 am to 6:00 pm

Lab Hours

Monday to Friday
7:30 am to 5:30 pm

X-Ray Hours

Monday to Friday
8:00 am to 5:30 pm

 Please visit Dr Anang at www.neuromdclinic.com

  Julius B.-M. Anang (MD, PhD, FRCPC)
Neurologist with Special Interest in
Movement Disorders

 

Office Telephone: (204) 925-9539 

Fax Number:  1-855-461-1857

 Availability: Appointment by Consultation/Referral Only

Clinical Interest:

Diagnosis and management of movement disorders:

  • Parkinson disease and Parkinson-like disorders
    • Including advanced therapies such as continuous levodopa-carbidopa intestinal gel infusion therapy (DUODOPA)
  • Tremor, dystonia, ataxia, tics, myoclonus, chorea
  • Botulinum toxin injection therapy for movement disorders
  • Dyskinesias and drug-induced movement disorders etc.
  • Neurological aspects of sleep disorders including sleep related movement disorders
  • Selected areas of general neurology

Research Interests:

Tremor management and rehabilitation

Diagnosis and management of complications of Parkinson disease

Medical School:

Johannes Gutenberg University Mainz, Germany

Neurology residency:

University of Saskatchewan, University of Manitoba

Movement Disorders Fellowship:

McGill University, Montreal, Canada

Others:

Postgraduate Studies in Internal Medicine: Charite Berlin, Germany

Languages:

English, French and German (consultations in any of these languages)

Peer-reviewed Publications:

1. Anang, J. Levodopa-Carbidopa-Related Rash in Parkinson’s Disease: A Case Series. Can J Neurol Sci. 2018 Sep;45(5):588 -589. Doi: https://doi.org/10.1017/cjn.2018.58

2. Dawson B, Fereshtehnejad SM, Anang JBM, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB. Office-Based Screening for Dementia in Parkinson DiseaseThe Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts. JAMA Neurol. Published online March 26, 2018. Doi: http://dx.doi.org/10.1001/jamaneurol.2018.0254

3. Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D and Lang AE. Caffeine as Symptomatic Treatment for Parkinson’s Disease (Café-PD): A Randomized Trial. Neurology 2017 Oct 24;89(17):1795-1803. Doi: http://dx.doi.org/10.1212/WNL.0000000000004568

4. Anang JBM, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB. Dementia Predictors in Parkinson Disease: A Validation Study. J Parkinson’s Disease 2017; 7(1) 159 -162. Doi: http://dx.doi.org/10.3233/JPD-160925 

5. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. JAMA Neurol. 2015 Aug;72(8):863-73. Doi: http://dx.doi.org/10.1001/jamaneurol.2015.0703

6. Romenets SR, Anang J, Fereshtehnejad SM, Pelletier A, Postuma RB. Tango for treatment of motor and non-motor manifestations in Parkinson’s disease: A Randomized control study. Complementary Therapies in Medicine 2015; 23:175-184. Doi:http://dx.doi.org/10.1016/j.ctim.2015.01.015

7. Kawada T, Anang JB, Postuma R. Predictors of dementia in Parkinson disease: A prospective cohort study. Author response. Neurology 2015; 84(12): 1285-6. Doi: http://dx.doi.org/10.1212/WNL.0000000000001408

8. Anang JB, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB. Predictors of dementia in Parkinson disease: A prospective cohort study. Neurology 2014; 83(14): 1253-60. Doi:  http://dx.doi.org/10.1212/WNL.0000000000000842

9. Anang J and Tellez-Zenteno JF (2012). Single Unprovoked Seizure: Wait Time to Full Medical Assessment, Does it Matter? Neurol. Bull. 2012; 4: 1 – 11. Doi: http://dx.doi.org/10.7191/neurol_bull. 2012.1035

Published Manuscripts and books:

1. Compendium of Basic and Clinical Research in Advanced Parkinson’s Disease. Highlights from the 2018 International Congress of Parkinson’s Disease and Movement Disorders. A Canadian Perspective. Reviewed by the Schulich School of Medicine and Dentistry, University of Western Ontario, Canada. Co-author. Click to download or here

2. Compendium of Basic and Clinical Research in Advanced Parkinson’s Disease. Highlights from the International Congress of Parkinson’s Disease and Movement Disorders 2017. A Canadian Perspective. Reviewed by the Schulich School of Medicine and Dentistry, University of Western Ontario, Canada.Co-author.

3 .Basic and Clinical Research Update in Parkinson’s disease. Highlights from the 4th World Parkinson Congress 2016: A Canadian Perspective. September 20-23, Portland, Oregon, USA. Reviewee by the Schulich School of Medicine and Dentistry, University of Western Ontario, Canada. Co-author.

4. Parkinson’s Disease. An Introductory Guide (patient education).

Ron Postuma and Julius Anang. Published in 2017. Download here